The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 179, 5977 -5989
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, J.
Right arrow Articles by Hsu, K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, J.
Right arrow Articles by Hsu, K. C.

Hierarchy of the Human Natural Killer Cell Response Is Determined by Class and Quantity of Inhibitory Receptors for Self-HLA-B and HLA-C Ligands1

Junli Yu*, Glenn Heller{dagger}, Joseph Chewning{ddagger}, Sungjin Kim, Wayne M. Yokoyama and Katharine C. Hsu2,§

* Immunology Program, {dagger} Department of Epidemiology and Biostatistics, {ddagger} Department of Pediatrics, and § Department of Medicine, Sloan-Kettering Cancer Center, New York, NY 10021; and Howard Hughes Medical Institute, Department of Medicine, Washington University, St. Louis, MO 63110

The interaction of NK inhibitory killer Ig-like receptors (KIRs) with self-MHC class I molecules mediates NK tolerance to self while conferring functional competence. Through single-cell analysis of intracellular IFN-{gamma} production and NK clone cytotoxicity we evaluated the resting NK repertoire, analyzing the responsiveness of NK subgroups expressing discrete combinations of non-KIR and KIR class I-specific receptors. CD94:NKG2A and Ig-like transcript 2 (ILT2)-expressing cells have a modest response to class I-negative target cells, but NK cells expressing inhibitory KIRs to self-MHC class I ligands, both HLA-B and HLA-C ligands, achieve significantly higher effector capacity. There is a dose effect of KIR for self-MHC on effector capacity, but even in the most highly responsive NK cells expressing more than one inhibitory KIR for self-MHC the presentation of only one cognate MHC ligand is sufficient to abolish response. Among KIR+ cells there is preferential expression for inhibitory KIR for self-MHC. The likelihood of KIR expression is influenced by whether other KIRs are already expressed on the same cell, supporting a model of serial acquisition of KIR expression. These findings define how inhibitory receptor and autologous HLA interactions impact single-cell function and demonstrate that the resting human NK repertoire is highly attuned but variegated in response. These findings have important implications for the resting NK response to viral pathogens and malignancy, for donor selection in allogeneic hemopoietic cell transplantation, and for models of NK tolerance.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported in part by Marrow Foundation Grant 1K04-01 (to K.C.H.) and National Institutes of Health Grant HL070053 (to K.C.H.).

2 Address correspondence and reprint requests to Dr. Katharine C. Hsu, Adult Allogeneic Bone Marrow Transplantation Service, Department of Medicine, Box 336, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021. E-mail address: hsuk{at}mskcc.org

3 Abbreviations used in this paper: ILT2, Ig-like transcript 2; AHSCT, allogeneic hemopoietic stem cell transplantation; BLCL, B lymphoblastoid cell line; KIR, killer Ig-like receptor; NS-KIR, inhibitory KIR expressed by NK cells for nonself-MHC class I; S-KIR, inhibitory KIR expressed by NK cells for self-MHC class I.


Related articles in The JI:

IN THIS ISSUE

The JI 2007 179: 5615-5616. [Full Text]  



This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Sola, P. Andre, C. Lemmers, N. Fuseri, C. Bonnafous, M. Blery, N. R. Wagtmann, F. Romagne, E. Vivier, and S. Ugolini
Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo
PNAS, August 4, 2009; 106(31): 12879 - 12884.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. M. Burt, G. Plitas, Z. Zhao, Z. M. Bamboat, H. M. Nguyen, B. Dupont, and R. P. DeMatteo
The Lytic Potential of Human Liver NK Cells Is Restricted by Their Limited Expression of Inhibitory Killer Ig-Like Receptors
J. Immunol., August 1, 2009; 183(3): 1789 - 1796.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Andersson, C. Fauriat, J.-A. Malmberg, H.-G. Ljunggren, and K.-J. Malmberg
KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression
Blood, July 2, 2009; 114(1): 95 - 104.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Yu, J. M. Venstrom, X.-R. Liu, J. Pring, R. S. Hasan, R. J. O'Reilly, and K. C. Hsu
Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation
Blood, April 16, 2009; 113(16): 3875 - 3884.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. T. Joncker, N. C. Fernandez, E. Treiner, E. Vivier, and D. H. Raulet
NK Cell Responsiveness Is Tuned Commensurate with the Number of Inhibitory Receptors for Self-MHC Class I: The Rheostat Model
J. Immunol., April 15, 2009; 182(8): 4572 - 4580.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Brodin, T. Lakshmikanth, S. Johansson, K. Karre, and P. Hoglund
The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells
Blood, March 12, 2009; 113(11): 2434 - 2441.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Fauriat, S. Andersson, A. T. Bjorklund, M. Carlsten, M. Schaffer, N. K. Bjorkstrom, B. C. Baumann, J. Michaelsson, H.-G. Ljunggren, and K.-J. Malmberg
Estimation of the Size of the Alloreactive NK Cell Repertoire: Studies in Individuals Homozygous for the Group A KIR Haplotype
J. Immunol., November 1, 2008; 181(9): 6010 - 6019.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. N. Bimber, A. J. Moreland, R. W. Wiseman, A. L. Hughes, and D. H. O'Connor
Complete Characterization of Killer Ig-Like Receptor (KIR) Haplotypes in Mauritian Cynomolgus Macaques: Novel Insights into Nonhuman Primate KIR Gene Content and Organization
J. Immunol., November 1, 2008; 181(9): 6301 - 6308.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Vago, B. Forno, M. P. Sormani, R. Crocchiolo, E. Zino, S. Di Terlizzi, M. T. Lupo Stanghellini, B. Mazzi, S. K. Perna, A. Bondanza, et al.
Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation
Blood, October 15, 2008; 112(8): 3488 - 3499.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Yawata, N. Yawata, M. Draghi, F. Partheniou, A.-M. Little, and P. Parham
MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response
Blood, September 15, 2008; 112(6): 2369 - 2380.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Kim, J. B. Sunwoo, L. Yang, T. Choi, Y.-J. Song, A. R. French, A. Vlahiotis, J. F. Piccirillo, M. Cella, M. Colonna, et al.
HLA alleles determine differences in human natural killer cell responsiveness and potency
PNAS, February 26, 2008; 105(8): 3053 - 3058.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.